Related Experiment Videos

Pyruvate carboxylase deficiency--insights from liver transplantation

William L Nyhan1, Ajai Khanna, Bruce A Barshop

  • 1Department of Pediatrics, University of California, San Diego, La Jolla, CA, USA. WNyahan@USCD.edu

Insights

Pyruvate carboxylase deficiency causes severe metabolic acidosis in infants. While glucose helped ketoacidosis, liver transplantation successfully treated ketoacidosis and improved lactic acidosis in one infant.

Area of Science:

  • Biochemistry
  • Pediatric Medicine
  • Metabolic Disorders

Background:

  • Pyruvate carboxylase deficiency (PCD) is a rare genetic disorder.
  • The complex form presents with lethal metabolic acidosis, ketoacidosis, lactic acidemia, renal tubular acidosis, hyperammonemia, and citrullinemia.

Observation:

  • In an infant with PCD, high glucose levels initially improved ketoacidosis but exacerbated lactic acidosis.
  • Orthotopic liver transplantation was performed to address the metabolic derangements.

Findings:

  • Liver transplantation completely resolved ketoacidosis and renal tubular abnormalities.
  • Lactic acidemia was ameliorated post-transplantation.
  • Cerebrospinal fluid glutamine levels remained low and did not recover after transplantation.

Implications:

  • Orthotopic liver transplantation is a potential therapeutic strategy for complex pyruvate carboxylase deficiency.
  • The persistent low CSF glutamine suggests ongoing metabolic dysfunction or limited substrate availability despite successful liver transplant.
  • Further research is needed to understand the long-term neurological outcomes and metabolic management in PCD patients.

Related Concept Videos